These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 37493099)
21. IMMUNOHISTOCHEMISTRY IN ENDOMETRIAL HYPERPLASIA AND ENDOMETRIAL ADENOCARCINOMA. Socolov D; Socolov R; Lupascu IA; Rugina V; Gabia O; Garauleanu DM; Carauleanu A Rev Med Chir Soc Med Nat Iasi; 2016; 120(2):355-62. PubMed ID: 27483717 [TBL] [Abstract][Full Text] [Related]
22. Cervical stromal involvement by endometrial 'hyperplasia': a previously unreported phenomenon with recommendations to report as stage II endometrial carcinoma. Taylor J; McCluggage WG Pathology; 2021 Aug; 53(5):568-573. PubMed ID: 34154843 [TBL] [Abstract][Full Text] [Related]
23. Endometrioid carcinomas of the uterine corpus with sex cord-like formations, hyalinization, and other unusual morphologic features: a report of 31 cases of a neoplasm that may be confused with carcinosarcoma and other uterine neoplasms. Murray SK; Clement PB; Young RH Am J Surg Pathol; 2005 Feb; 29(2):157-66. PubMed ID: 15644772 [TBL] [Abstract][Full Text] [Related]
24. CD10 and calretinin staining of endocervical glandular lesions, endocervical stroma and endometrioid adenocarcinomas of the uterine corpus: CD10 positivity is characteristic of, but not specific for, mesonephric lesions and is not specific for endometrial stroma. McCluggage WG; Oliva E; Herrington CS; McBride H; Young RH Histopathology; 2003 Aug; 43(2):144-50. PubMed ID: 12877729 [TBL] [Abstract][Full Text] [Related]
25. The behavior of endometrial hyperplasia. A long-term study of "untreated" hyperplasia in 170 patients. Kurman RJ; Kaminski PF; Norris HJ Cancer; 1985 Jul; 56(2):403-12. PubMed ID: 4005805 [TBL] [Abstract][Full Text] [Related]
26. [Endometrial atypical complex hyperplasia with extensive squamous metaplasia: two cases]. Hannachi Sassi S; Dhouib R; Abbes I; Braham E; Mrad K; Driss M; Ben Hamida N; Ben Romdhane K Ann Pathol; 2008 Jun; 28(3):233-6. PubMed ID: 18706369 [TBL] [Abstract][Full Text] [Related]
27. Corded and Hyalinized Endometrioid Endometrial Carcinoma: A Rare Case Treated With Robot-Assisted Surgery. Kawashima H; Fukuda T; Sakamoto K; Yamauchi M; Sumi T Cureus; 2024 Jun; 16(6):e62274. PubMed ID: 39006655 [TBL] [Abstract][Full Text] [Related]
28. Expression of cyclin D1 in normal, metaplastic, hyperplastic endometrium and endometrioid carcinoma suggests a role in endometrial carcinogenesis. Ruhul Quddus M; Latkovich P; Castellani WJ; James Sung C; Steinhoff MM; Briggs RC; Miranda RN Arch Pathol Lab Med; 2002 Apr; 126(4):459-63. PubMed ID: 11900573 [TBL] [Abstract][Full Text] [Related]
29. Cellular features of endometrial hyperplasia and well differentiated adenocarcinoma using the Endocyte sampler: Diagnostic criteria based on the cytoarchitecture of tissue fragments. Norimatsu Y; Shimizu K; Kobayashi TK; Moriya T; Tsukayama C; Miyake Y; Ohno E Cancer; 2006 Apr; 108(2):77-85. PubMed ID: 16463402 [TBL] [Abstract][Full Text] [Related]
30. Simple and complex hyperplastic papillary proliferations of the endometrium: a clinicopathologic study of nine cases of apparently localized papillary lesions with fibrovascular stromal cores and epithelial metaplasia. Lehman MB; Hart WR Am J Surg Pathol; 2001 Nov; 25(11):1347-54. PubMed ID: 11684950 [TBL] [Abstract][Full Text] [Related]
31. Expression and significance of beta-catenin, Glut-1 and PTEN in proliferative endometrium, endometrial intraepithelial neoplasia and endometrioid adenocarcinoma. Xiong Y; Xiong YY; Zhou YF Eur J Gynaecol Oncol; 2010; 31(2):160-4. PubMed ID: 20527231 [TBL] [Abstract][Full Text] [Related]
32. Clear cell carcinoma of the endometrium is characterized by a distinctive profile of p53, Ki-67, estrogen, and progesterone receptor expression. Lax SF; Pizer ES; Ronnett BM; Kurman RJ Hum Pathol; 1998 Jun; 29(6):551-8. PubMed ID: 9635673 [TBL] [Abstract][Full Text] [Related]
33. [Outcome analysis of conservative treatment of well-differentiated endometrial adenocarcinoma and severe atypical hyperplasia in young women]. Yu M; Shen K; Yang JX; Huang HF; Wu M; Pan LY; Lang JH; Lian LJ Zhonghua Fu Chan Ke Za Zhi; 2006 Apr; 41(4):242-5. PubMed ID: 16759458 [TBL] [Abstract][Full Text] [Related]
34. GLUT-1 Expression in Proliferative Endometrium, Endometrial Hyperplasia, Endometrial Adenocarcinoma and the Relationship Between GLUT-1 Expression and Prognostic Parameters in Endometrial Adenocarcinoma. Canpolat T; Ersöz C; Uğuz A; Vardar MA; Altintaş A Turk Patoloji Derg; 2016; 32(3):141-7. PubMed ID: 27562387 [TBL] [Abstract][Full Text] [Related]
35. Association of ovarian hyperthecosis with endometrial polyp, endometrial hyperplasia, and endometrioid adenocarcinoma in postmenopausal women: a clinicopathological study of 238 cases. Zhang C; Sung CJ; Quddus MR; Simon RA; Jazaerly T; Lawrence WD Hum Pathol; 2017 Jan; 59():120-124. PubMed ID: 27746268 [TBL] [Abstract][Full Text] [Related]
36. Endometrial serous carcinoma with a corded and hyalinized pattern: a clinicopathological and molecular analysis. Travaglino A; Santoro A; Arciuolo D; Scaglione G; Raffone A; Piermattei A; Onori ME; Minucci A; Pedone Anchora L; Fanfani F; Zannoni GF Pathologica; 2024 Jun; 116(3):176-179. PubMed ID: 38979592 [TBL] [Abstract][Full Text] [Related]
37. [Precursor lesions of endometrial carcinoma: diagnostic approach and molecular pathology]. Lax S Pathologe; 2011 Nov; 32 Suppl 2():255-64. PubMed ID: 22033684 [TBL] [Abstract][Full Text] [Related]